1.	Aromatase Inhibitor Clinical Trial Phase: Phase IV Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 40 to 70 Sponsor: NIGMS Protocol IDs: 0412-14, UO1-GM61373-06, NCT00228956
2.	Use of the Contura™ Catheter to Deliver Accelerated Partial Breast Irradiation to "Low-Risk" Breast Cancer Patients Phase: Phase IV Type: Treatment Status: Active Age: 50 and over Sponsor: Other Protocol IDs: S07-002, 1098558, NCT00882596
3.	Phase IV Trial to Evaluate Breast Brachytherapy Using the Mammosite-Ml® Phase: Phase IV Type: Treatment Status: Active Age: 45 and over Sponsor: Other Protocol IDs: Mammosite ML, NCT01448447
4.	MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I Phase: Phase IV Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: P0334, NCT01501487
5.	Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System Phase: Phase IV Type: Treatment Status: Active Age: 40 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CTPR-0009, NCT01644669
6.	Diindolylmethane in Treating Patients With Breast Cancer Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Active Age: 19 and over Sponsor: NCI, Other Protocol IDs: 10-0366-04, NCI-2011-00710, NCT01391689
7.	Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000409590, NSABP-B-39, RTOG-0413, SWOG-NSABP-B-39, NCT00103181
8.	Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2009-00702, NSABP-B-43, CDR0000615085, U10CA012027, NCT00769379
9.	Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy Phase: Phase III Type: Treatment Status: Active Age: 40 and over Sponsor: Other Protocol IDs: 2009-APBI, WIRB #20091193, NCT01185132
10.	Higher-Dose Radiation Therapy or Standard Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: RTOG 1005, NCI-2011-02669, CDR0000700069, NCT01349322
11.	Prospective Trial of Two Prone Breast Radiotherapy Techniques With Randomization to Concurrent Versus Weekly Boost Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: S12-01299, NCT01591811
12.	Percutaneous Removal and Margin Ablation for Breast Cancer Phase: Phase II, Phase I Type: Diagnostic, Treatment Status: Active Age: 18 to 90 Sponsor: Other Protocol IDs: UAMS 07050, NIH Grant 5 R21 CA097715-01, NCT00574301
13.	Vaccine Therapy in Treating Patients With Ductal Carcinoma In Situ of the Breast Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000644921, UPCC-15107, 807010, NCT00923143
14.	Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Adult Sponsor: Other Protocol IDs: 2008NTLS083, UMN-0809M45461, UMN-2008NTLS083, NCT01009437
15.	Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial) Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: IFHCC 09-002, NCT01023477
16.	Single Fraction Intraoperative Radiotherapy Phase: Phase II, Phase I Type: Treatment Status: Active Age: 41 and over Sponsor: Other Protocol IDs: 12-001 Single Fraction IORT, NCT01688388
17.	Mammosite Breast Brachytherapy Optimization in the Treatment of Breast Carcinoma Phase: Phase II Type: Treatment Status: Active Age: 30 and over Sponsor: Other Protocol IDs: 0601000957, NCT00611624
18.	Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS) Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: DCIS-WHM-703M, NCT00669747
19.	Radiation Therapy in Treating Women With Early Stage Breast Cancer Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 040807, CDR0000643276, CINJ-040807, NCT00909909
20.	Study to Evaluate the Effect of Sulforaphane in Broccoli Sprout Extract on Breast Tissue Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: J0822, NCT00982319
21.	Internal Radiation Therapy of the Breast in Treating Women With Early-Stage Breast Cancer Phase: Phase II Type: Treatment Status: Active Age: 50 and over Sponsor: Other Protocol IDs: 040902, CDR0000660027, S09-001, CINJ-040902, NCT01019720
22.	Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: RTOG 1014, CDR0000666991, NCT01082211
23.	Safety Study for Short-course Accelerated, Hypofractionated Partial Breast Radiotherapy (APBI) in Women With Early Stage Breast Cancer Using the Contura MLB Phase: Phase II Type: Treatment Status: Active Age: 50 and over Sponsor: Pharmaceutical / Industry Protocol IDs: S09-001, NCT01072838
24.	Laboratory-Treated T Cells After Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer Undergoing Surgery Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000675211, P30CA022453, WSU-2010-056, 2010-056, NCT01147016
25.	Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer Phase: Phase II Type: Natural history/Epidemiology, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 10-114, NCT01203839